Skip to main content
Clinical Trials/CTRI/2024/01/061403
CTRI/2024/01/061403
Completed
未知

Comparative assessment of efficacy of intralesional injection of placentrex, hyalouronidase and dexamethasone in treatment of Oral submucous fibrosis- A randomized control trial - NIl

Jay Goyal0 sites160 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: 3- Administration
Sponsor
Jay Goyal
Enrollment
160
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Jay Goyal

Eligibility Criteria

Inclusion Criteria

  • The patients diagnosed with Grade 2, and Grade 3 of oral submucous fibrosis (OSMF), as evident from their detailed clinical and histopathological examination

Exclusion Criteria

  • The patients with previous treatment of OSMF, patients who had Grade 1 and 4 OSMF, who were allergic to placental extract, steroids, and hyaluronidase, the patients who did not give their consents, who have syndromic or systemic disease with mouth ulcers, who had undergone radiotherapy sessions leading to oral ulcers, those who gave previous history of major surgery in the oral cavity, patients with carcinoma of oral cavity, were excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials